22 min listen
PARP Inhibition in the Management of Pancreatic Cancer
PARP Inhibition in the Management of Pancreatic Cancer
ratings:
Length:
47 minutes
Released:
Oct 23, 2020
Format:
Podcast episode
Description
For this special edition of Oncology Today, I met with Dr Kim Reiss Binder from the Abramson Cancer Center in Philadelphia to discuss recently published and emerging research on the use of PARP inhibitors in pancreatic cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPARPPanc20).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPARPPanc20).
Released:
Oct 23, 2020
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love